B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Introduction: B lymphocytes might play a pathogenic role in dermal fibrosis in systemic sclerosis (SSc). B-cell activating factor (BAFF), a key cytokine for B-cell activation, is increased in the serum and the skin of patients with SSc. However, the ability of B cells directly to stimulate dermal fibroblasts and the role of BAFF are not fully understood. We therefore investigated the involvement of B cells and BAFF in the expression of collagen and profibrotic markers by dermal fibroblasts. Methods: Cocultures of blood B cells from healthy blood donors and normal or SSc dermal fibroblasts stimulated with anti-IgM and BAFF were performed. Alpha-SMA, TIMP1, MMP9, COL1A1, COL1A2, and COL3A1 mRNA expression were determined by quantitative RT-PCR. Soluble collagen, BAFF, IL-6, IL-1β, TGF-β1, and CCL2 protein secretion were assessed. Results: Coculture of blood B cells and dermal fibroblasts isolated from SSc patients induced IL-6, TGF-β1, CCL2, and collagen secretion, as well as Alpha-SMA, TIMP1, and MMP9 expression in dermal fibroblasts. Transwell assays demonstrated that this induction was dependent on cell-cell contact. Addition of anti-IgM and BAFF to the coculture increased IL-6, CCL2, TGF-β1, and collagen secretion. B cell- and BAFF-induced collagen secretion was highly reduced by anti-TGF-β1 antibodies. Conclusions: Our results showed for the first time a direct role of B cells on the production of collagen by dermal fibroblasts, which is further enhanced by BAFF. Thus, these results demonstrate a new pathogenic role of B cells and BAFF in fibrosis and systemic sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For this effect cell-cell contact was required, as the use of a transwell system negated the stimulatory effect of B cells on fibroblast activity (175).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [175]
In the citing paper
“Finally, B lymphocytes have also been demonstrated to be able to promote fibrosis; co-culture of B cells with skin fibroblasts induced the expression of collagen and αSMA by the latter (175).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [175]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Mackay, F., & Schneider, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2572 · Cited by 930
Ng, L. G., Sutherland, A. P. R., Newton, R., Qian, F., Cachero, T. G., Scott, M. L., Thompson, J. S., Wheway, J., Chtanova, T., Groom, J., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.807 · Cited by 500
Systemic and cell type-specific gene expression patterns in scleroderma skin
Whitfield, M. L., Finlay, D. R., Murray, J. I., Troyanskaya, O. G., Chi, J.-T., Pergamenschikov, A., McCalmont, T. H., Brown, P. O., Botstein, D., & Connolly, M. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635114100 · Cited by 409
Duncan, M. R., & Berman, B. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12483971 · Cited by 323
Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity
Sato, S., Hasegawa, M., Fujimoto, M., Tedder, T. F., & Takehara, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6635 · Cited by 320
Sato, S., Fujimoto, M., Hasegawa, M., & Takehara, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20274 · Cited by 317
Mart�nez-Lav�n, M., Hermosillo, A. G., Rosas, M., & Soto, M.-E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199811)41:11<1966::aid-art11>3.0.co;2-o · Cited by 306
Research works printed but not linked: 1
- Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM: Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Arthritis Rheum. 1998, 41: 2039-2047. 10.1002/1529-0131(199811)41:11<2039::AID-ART20>3.0.CO;2-1. · DOI · Paper page
Cited by
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Crosstalk between fibroblasts and inflammatory cells
Van Linthout, S., Miteva, K., & Tschope, C. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu062 · Cited by 569
Möckel, T., Basta, F., Weinmann-Menke, J., & Schwarting, A. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102736 · Cited by 228
Immunology of IgG4-related disease
Della-Torre, E., Lanzillotta, M., & Doglioni, C. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12641 · Cited by 226
Daoussis, D., Melissaropoulos, K., Sakellaropoulos, G., Antonopoulos, I., Markatseli, T. E., Simopoulou, T., Georgiou, P., Andonopoulos, A. P., Drosos, A. A., Sakkas, L., et al. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.10.003 · Cited by 217
Potential approaches to reverse or repair renal fibrosis
Tampe, D., & Zeisberg, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.14 · Cited by 195
The immunopathogenesis of fibrosis in systemic sclerosis
Brown, M., & O’Reilly, S. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13238 · Cited by 190
Current Concepts on the Pathogenesis of Systemic Sclerosis
Truchetet, M. E., Brembilla, N. C., & Chizzolini, C. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08889-8 · Cited by 170
Transcriptional regulatory model of fibrosis progression in the human lung
McDonough, J. E., Ahangari, F., Li, Q., Jain, S., Verleden, S. E., Herazo-Maya, J., Vukmirovic, M., DeIuliis, G., Tzouvelekis, A., Tanabe, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131597 · Cited by 174
Pathophysiology of systemic sclerosis (scleroderma)
Rosendahl, A., Schönborn, K., & Krieg, T. (2022) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12505 · Cited by 160
Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis
Mavropoulos, A., Simopoulou, T., Varna, A., Liaskos, C., Katsiari, C. G., Bogdanos, D. P., & Sakkas, L. I. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39437 · Cited by 161
Trained immunity modulates inflammation-induced fibrosis
Jeljeli, M. M., Riccio, L. G. C., Doridot, L., Chêne, C., Nicco, C., Chouzenoux, S., Deletang, Q., Allanore, Y., Kavian, N., & Batteux, F. (2019) · Nature Communications · doi:10.1038/s41467-019-13636-x · Cited by 172
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease
Della‐Torre, E., Rigamonti, E., Perugino, C. A., Sain, S. B., Sun, N., Kaneko, N., Maehara, T., Rovati, L., Ponzoni, M., Milani, R., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.07.004 · Cited by 169
Matsushita, T., Kobayashi, T., Mizumaki, K., Kano, M., Sawada, T., Tennichi, M., Okamura, A., Hamaguchi, Y., Iwakura, Y., Hasegawa, M., et al. (2018) · Science Advances · doi:10.1126/sciadv.aas9944 · Cited by 158
Bosello, S. L., Luca, G. D. D., Rucco, M., Berardi, G., Falcione, M., Danza, F. M., Pirronti, T., & Ferraccioli, G. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.09.002 · Cited by 157
Unraveling SSc Pathophysiology; The Myofibroblast
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., & van der Kraan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02452 · Cited by 153
Giuggioli, D., Lumetti, F., Colaci, M., Fallahi, P., Antonelli, A., & Ferri, C. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.008 · Cited by 153
Della‐Torre, E., Feeney, E. R., Deshpande, V., Mattoo, H., Mahajan, V. S., Kulikova, M., Wallace, Z. S., Carruthers, M. N., Chung, R. T., Pillai, S. S., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205799 · Cited by 146
Gordon, J., Martyanov, V., Franks, J. M., Bernstein, E. J., Szymonifka, J. D., MAGRO, C. M. J., Wildman, H. F., Wood, T. A., Whitfield, M. L., & Spiera, R. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40358 · Cited by 143
The Roles of Immune Cells in the Pathogenesis of Fibrosis
Huang, E., Peng, N., Xiao, F., Hu, D., Wang, X., & Lu, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155203 · Cited by 143
Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells
Melissaropoulos, K., Iliopoulos, G., Sakkas, L. I., & Daoussis, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.925741 · Cited by 119
B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis
François, A., Gombault, A., Villeret, B., Alsaleh, G., Fanny, M., Gasse, P., Adam, S. M., Crestani, B., Sibilia, J., Schneider, P., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.08.003 · Cited by 109
“BAFF-related induction of Th17 cells could be related to the amplification by BAFF of the secretion of IL-6, a pivotal cytokine for Th17 polarization[46], as shown previously by our group[47,48] and others.”
BackgroundSelf-citationAltered B lymphocyte homeostasis and functions in systemic sclerosis
Forestier, A., Guerrier, T., Jouvray, M., Giovannelli, J., Lefèvre, G., Sobanski, V., Hauspie, C., HACHULLA, E., Hatron, P., Zéphir, H., et al. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.10.015 · Cited by 103
Current perspectives on the immunopathogenesis of systemic sclerosis
Fuschiotti, P. (2016) · ImmunoTargets and Therapy · doi:10.2147/itt.s82037 · Cited by 110
Dumoitier, N., Chaigne, B., Régent, A., Lofek, S., Mhibik, M., Dorfmüller, P., Terrier, B., London, J., BEREZNE, A., Tamas, N., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.40016 · Cited by 96
Schiopu, E., Chatterjee, S., Hsu, V., Flor, A., Cimbora, D., Patra, K., Yao, W., Li, J., Streicher, K., McKeever, K., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1021-2 · Cited by 81
TNF superfamily control of tissue remodeling and fibrosis
Steele, H., Cheng, J. H., Willicut, A., Dell, G., Breckenridge, J. E., Culberson, E., Ghastine, A., Tardif, V., & Herro, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219907 · Cited by 91
Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis
Fang, D., Chen, B., Lescoat, A., Khanna, D., & Mu, R. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00864-7 · Cited by 84
Bosello, S. L., Angelucci, C., Lama, G., Alivernini, S., Proietti, G., Tolusso, B., Sica, G., Gremese, E., & Ferraccioli, G. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1569-0 · Cited by 78
Role of B-Cell in the Pathogenesis of Systemic Sclerosis
Thoreau, B., Chaigne, B., & Mouthon, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933468 · Cited by 77
Pathogenic roles of B lymphocytes in systemic sclerosis
Yoshizaki, A. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.002 · Cited by 72
Ali, M. F., Egan, A. M., Shaughnessy, G. F., Anderson, D. K., Kottom, T. J., Dasari, H., Keulen, V. P. V., Aubry, M.-C., Yi, E. S., LIMPER, A. H., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0387oc · Cited by 68
Role of B cells in the pathogenesis of systemic sclerosis
Sanges, S., Guerrier, T., Launay, D., Lefèvre, G., Labalette, M., Forestier, A., Sobanski, V., Corli, J., Hauspie, C., Jendoubi, M., et al. (2016) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.02.016 · Cited by 76
Baird, K., Comis, L. E., Joe, G. O., Steinberg, S. M., Hakim, F. T., Rose, J. J., Mitchell, S. A., Pavletic, S. Z., Figg, W. D., Yao, L., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.006 · Cited by 68
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions
Liakouli, V., Ciancio, A., Galdo, F. D., Giacomelli, R., & Ciccia, F. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01044-x · Cited by 67
Worrell, J. C., & O’Reilly, S. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102526 · Cited by 64
Targeting B Lymphocytes in Progressive Fibrosing Mediastinitis
Westerly, B. D., Johnson, G. B., Maldonado, F., Utz, J. P., Specks, U., & Peikert, T. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1258le · Cited by 63
Carlavan, I., Bertino, B., Rivier, M., Martel, P., Bourdès, V., Motte, M., Déret, S., Reiniche, P., Ménigot, C., Khammari, A., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16680 · Cited by 63
Multimodality Imaging of Focal and Diffuse Fibrosing Mediastinitis
Garrana, S. H., Buckley, J. R., Rosado-de-Christenson, M. L., Martínez-Jiménez, S., Muñoz, P., & Borsa, J. J. (2019) · Radiographics · doi:10.1148/rg.2019180143 · Cited by 62
Lao, X., LIANG, Y.-J., Su, Y., ZHANG, S.-E., ZHOU, X., & Liao, G. (2016) · Oncology Letters · doi:10.3892/ol.2016.4184 · Cited by 61
Almeida, I., Silva, S. V., Fonseca, A. R., Silva, I., Vasconcelos, C., & Lima, M. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8505-8 · Cited by 56
Back to the future: targeting the extracellular matrix to treat systemic sclerosis
Leask, A., Naik, A., & Stratton, R. J. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01032-1 · Cited by 53
Lanteri, A., Sobanski, V., Langlois, C., Lefèvre, G., Hauspie, C., Sanges, S., Lambert, M., Morell‐Dubois, S., Hatron, P., HACHULLA, E., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.07.003 · Cited by 48
The role of the acquired immune response in systemic sclerosis
Chizzolini, C., & Boin, F. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0509-1 · Cited by 52
Streicher, K. L., Sridhar, S., Kuziora, M., Morehouse, C. A., Higgs, B. W., Sebastian, Y., Groves, C. J., Pilataxi, F., Brohawn, P. Z., Herbst, R., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40656 · Cited by 45
Contribution of Interleukin-6 to the Pathogenesis of Systemic Sclerosis
Kawaguchi, Y. (2017) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000258 · Cited by 44
Melsens, K., Vandecasteele, E. H., Deschepper, E., Badot, V., Blockmans, D., Brusselle, G., Langhe, E. D., Pauw, M. D., Debusschere, C., Decuman, S., et al. (2017) · Acta Clinica Belgica · doi:10.1080/17843286.2017.1372244 · Cited by 42
A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways
Jiménez, S. A., Mendoza, F. A., & Piera-Velázquez, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551911 · Cited by 43
Li, L., Shen, S., Shao, S., Dang, E., Wang, G., Fang, H., & Qiao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1538555 · Cited by 46
Olivares-Silva, F., Landaeta, R., Aránguiz, P., Bolívar, S., Humeres, C. D., Anfossi, R., Vivar, R., Boza, P., Muñoz, C., Pardo-Jiménez, V., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.002 · Cited by 38
Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species–Induced Mouse Model
Morin, F., Kavian, N., Nicco, C., Cerles, O., Chéreau, C., & Batteux, F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502482 · Cited by 39
Uppin, V., Gibbons, H. R., Troje, M., Feinberg, D. M., Webber, B. R., Moriarity, B. S., & Parameswaran, R. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103369 · Cited by 36
Daoussis, D., Tsamandas, A. C., Antonopoulos, I., Filippopoulou, A., Papachristou, D. J., Papachristou, N. I., Andonopoulos, A. P., & Liossis, S. C. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1017-y · Cited by 36
Garetto, S., Sardi, C., Martini, E., Roselli, G., Morone, D., Angioni, R., Cianciotti, B. C., Trovato, A. E., Franchina, D. G., Castino, G. F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9280 · Cited by 35
Sternbæk, L., Draborg, A. H., Østerlund, M. T., Iversen, L. V., Troelsen, L. N., Theander, E., Nielsen, C. T., Jacobsen, S., & Houen, G. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2018.1550807 · Cited by 34
Lima-Júnior, J. R., Arruda, L. C. M., Santana-Gonçalves, M., Dias, J. B. E., Moraes, D. A., Covas, D. T., Simões, B. P., Oliveira, M. C., & Malmegrim, K. C. R. (2021) · Rheumatology · doi:10.1093/rheumatology/keab257 · Cited by 34
B cells in systemic sclerosis: from pathophysiology to treatment
Μελισσαρόπουλος, Κ., & Daoussis, D. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05665-z · Cited by 34
Systemic sclerosis in adults. Part II: management and therapeutics
Jerjen, R., Nikpour, M., Krieg, T. M., Denton, C. P., & Saracino, A. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.10.066 · Cited by 35
Robles-Pérez, A., Dorca, J., Castellvi, I., Solé, J. M. N., Molina‐Molina, M., & Narváez, J. (2020) · Rheumatology International · doi:10.1007/s00296-020-04545-0 · Cited by 32
Use of biologics and other novel therapies for the treatment of systemic sclerosis
Bruni, C., Praino, E., Allanore, Y., Distler, O., Gabrielli, A., Iannone, F., & Matucci‐Cerinic, M. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1263153 · Cited by 31
Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?
McQueen, F. M., & Solanki, K. (2015) · Rheumatology · doi:10.1093/rheumatology/keu463 · Cited by 32
Changes in T cell and B cell composition in discoid lupus erythematosus skin at different stages
O’Brien, J. C., Hosler, G. A., & Chong, B. F. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.12.004 · Cited by 29
Emerging therapies for the treatment of systemic sclerosis
Distler, J. H. W., Kuwana, M., Assassi, S., & Denton, C. P. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01294-x · Cited by 29
Hsieh, S., Shen, C., Liao, H., Chen, M., Wu, C.-H., Li, K., Lu, C.-S., Kuo, Y., Tsai, H., Tsai, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145082 · Cited by 28
Vacchi, C., Manfredi, A., Cassone, G., Erre, G. L., Salvarani, C., & Sebastiani, M. (2021) · Drugs in Context · doi:10.7573/dic.2020-8-7 · Cited by 27
The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
Kim, S., Park, H. J., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416154 · Cited by 28
Sanges, S., Jendoubi, M., Kavian, N., Hauspie, C., Speca, S., Crave, J., Guerrier, T., Lefèvre, G., Sobanski, V., Savina, A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00053 · Cited by 25
Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development
Pieri, A. D., Korman, B. D., Jüngel, A., & Wuertz‐Kozak, K. (2021) · Advanced Biology · doi:10.1002/adbi.202000168 · Cited by 30
The role of B cells in the pathogenesis of systemic sclerosis: an update
Sakkas, L. I., Katsiari, C. G., Daoussis, D., & Bogdanos, D. P. (2022) · Rheumatology · doi:10.1093/rheumatology/keac578 · Cited by 26
Imbalance toward TFH 1 cells playing a role in aberrant B cell differentiation in systemic sclerosis
Ly, N. T. M., Ueda‐Hayakawa, I., Nguyen, C. T. H., Huynh, T. N., Kishimoto, I., Fujimoto, M., & Okamoto, H. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa669 · Cited by 28
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting
Romano, E., Rosa, I., Fioretto, B. S., Matucci‐Cerinic, M., & Manetti, M. (2021) · Current Molecular Medicine · doi:10.2174/0929867328666210325102749 · Cited by 26
B cells tell scleroderma fibroblasts to produce collagen
Daoussis, D., & Liossis, S. C. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4392 · Cited by 23
Cadherin-11 and cardiac fibrosis: A common target for a common pathology
Riley, L. A., & Merryman, W. D. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109876 · Cited by 21
Human cutaneous B cells: what do we really know?
Lerman, I., Mitchell, D. C., & Richardson, C. T. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5185 · Cited by 21
Association between cigarette smoking and impaired clinical symptoms in systemic sclerosis: A review
Zhang, Y.-J., Zhang, L., Huang, X.-L., Duan, Y., Yang, L., & Wang, J. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.04.002 · Cited by 19
Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?
van Rhijn-Brouwer, F. C. C.-C., Spierings, J., & van Laar, J. M. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.11.005 · Cited by 19
Immunotherapy of systemic sclerosis
Katsiari, C. G., Simopoulou, T., Alexiou, I., & Sakkas, L. I. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1491508 · Cited by 23
Leflunomide prevents ROS-induced systemic fibrosis in mice
Morin, F., Kavian, N., Chouzenoux, S., Cerles, O., Nicco, C., Chéreau, C., & Batteux, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.035 · Cited by 20
The Role of B Cells in Scleroderma Lung Disease Pathogenesis
Liossis, S. C., & Staveri, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.936182 · Cited by 19
Polychromatic flow cytometry in evaluating rheumatic disease patients
Wei, C., Jenks, S. A., & Sanz, I. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0561-1 · Cited by 19
Μελισσαρόπουλος, Κ., & Liossis, S. C. (2018) · Rheumatology International · doi:10.1007/s00296-018-4076-3 · Cited by 19
Wortel, C. M., Liem, S. I. E., van Leeuwen, N. M., Boonstra, M., Fehres, C. M., Stöger, J. L., Huizinga, T. W. J., Toes, R. E. M., de Vries-Bouwstra, J. K., & Scherer, H. U. (2023) · RMD Open · doi:10.1136/rmdopen-2023-003148 · Cited by 17
B lymphocytes in renal interstitial fibrosis
Zhu, F., Bai, X., & Chen, X. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0382-x · Cited by 17
TFH cells in systemic sclerosis
Beurier, P., Ricard, L., Eshagh, D., Malard, F., Siblany, L., Fain, O., Mohty, M., Gaugler, B., & MEKINIAN, A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03049-0 · Cited by 17
Moog, M., Hinze, C. A., Bormann, T., Aschenbrenner, F., Knudsen, L., DeLuca, D. S., Jonigk, D. D., Neubert, L., Welte, T., Gauldie, J., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100767 · Cited by 17
Roberson, E. D. O., Carns, M. A., Cao, L. H., Aren, K., Goldberg, I. A., Morales-Heil, D. J., Korman, B. D., Atkinson, J. P., & Varga, J. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42281 · Cited by 16
The Evolving Landscape of B Cells in Cancer Metastasis
Ramos, M. J., Lui, A. J., & Hollern, D. P. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0620 · Cited by 16
Shi, Y., You, H., Liu, C., Qiu, Y., Lv, C., Zhu, Y., Xu, L., Wang, F., Zhang, M., & Tan, W. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03153-6 · Cited by 16
B cells as target for immunotherapy in rheumatic diseases – current status
Bryl, E. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.05.006 · Cited by 16
B-cells in systemic sclerosis: emerging evidence from genetics to phenotypes
Wu, M., & Mohan, C. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000215 · Cited by 16
Distinct molecular subtypes of systemic sclerosis and gene signature with diagnostic capability
Wang, Q., Li, C., Wu, L., Hu, J., Yu, Q., Zhang, S., & He, P. F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1257802 · Cited by 15
Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease
Streutker, E. M., Devamoglu, U., Vonk, M. C., Verdurmen, W. P. R., & Gac, S. L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303991 · Cited by 18
Vasconcelos, M., Santana-Gonçalves, M., Zanin-Silva, D. C., Malmegrim, K. C. R., & Oliveira, M. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941011 · Cited by 16
Kanemitsu‐Okada, K., Abe, M., Nakamura, Y., Miyake, T., Watanabe, T., Yoshida, O., Koizumi, Y., Hirooka, M., Tokumoto, Y., Matsuura, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032509 · Cited by 15
Tsidulko, A. Y., Matskova, L. V., Astakhova, L., Ernberg, I. T., & Витальевна, Г. Э. (2015) · Oncotarget · doi:10.18632/oncotarget.5984 · Cited by 15
Properties and Immune Function of Cardiac Fibroblasts
Furtado, M. B., & Hasham, M. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57613-8_3 · Cited by 15
Targeted delivery in scleroderma fibrosis
Varrica, C., Dias, H. S., Reis, C. P., Carvalheiro, M. C., & Simões, S. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102730 · Cited by 15
Systemic sclerosis: The need for structured care
Morrisroe, K., Frech, T., Gote-Schniering, J., Maurer, B., & Nikpour, M. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.04.004 · Cited by 14
Rossi, D., Sciascia, S., Cecchi, I., Saracco, M., Montabone, E., Modena, V., Pellerito, R., CARIGNOLA, R., & Roccatello, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020292 · Cited by 11
The expanding impact of T-regs in the skin
Hajam, E. Y., Panikulam, P., Chu, C.-C., Jayaprakash, H., Majumdar, A., & Jamora, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983700 · Cited by 12
Metadata
- Authors
- François, A., Chatelus, E., Wachsmann, D., Sibilia, J., Bahram, S., Alsaleh, G., & Gottenberg, J.-E.
- Affiliations
- Inserm (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Corresponding author
- Gottenberg, Jacques-Eric
- Venue
- Arthritis Research & Therapy
- Published
- 2013-10-28
- Volume
- 15
- Issue
- 5
- Pages
- R168-R168
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC3978899
- OpenAlex
- W2158070434
- Cited by
- 149
- References
- 38
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 12 · 2023: 13 · 2022: 15 · 2021: 14 · 2020: 10 · 2019: 9 · 2018: 12 · 2017: 13 · 2016: 15 · 2015: 10 · 2014: 7 · 2013: 1
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion, other-oa)
- univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- systemic sclerosis, B cells, B-cell activating factor, dermal fibroblasts, skin fibrosis, collagen synthesis, TGF-β1, interleukin-6, MCP-1, alpha-smooth muscle actin, TIMP-1, MMP-9, cell-cell contact, anti-IgM stimulation
- MeSH terms
- Actins, Antibodies, Anti-Idiotypic, B-Lymphocytes, Cells, Cultured, Collagen, Enzyme-Linked Immunosorbent Assay, Fibroblasts, Fibrosis, Humans, Immunoglobulin M, Muscle, Smooth, Scleroderma, Systemic, Skin, Interleukin-6, Gene Expression, Coculture Techniques, Chemokine CCL2, Tissue Inhibitor of Metalloproteinase-1, Reverse Transcriptase Polymerase Chain Reaction, Matrix Metalloproteinase 9, B-Cell Activating Factor, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.